Perseus Proteomics Inc (4882) Stock Price & News

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	36.53M	43.10M	31.90M	35.18M
Cost of goods sold	1.20M	9.68M	6.32M	3.19M
Cost of revenue	1.20M	9.68M	6.32M	3.19M
Research and development expenses	145.28M	134.52M	128.48M	149.55M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	71.76M	73.28M	68.72M	86.71M
Operating expense	217.04M	207.80M	197.20M	236.26M
Total operating expenses	218.23M	217.48M	203.52M	239.45M
Operating income	-181.70M	-174.38M	-171.62M	-204.27M
Other non operating income	-395.00K	-176.00K	-4.82M	-2.26M
EBT including unusual items	-203.41M	-167.34M	-170.66M	-202.12M
EBT excluding unusual items	-175.51M	-162.33M	-170.67M	-201.61M
Income tax expense	-481.00K	1.44M	-445.00K	481.00K
Effective tax rate	0.24%	-0.86%	0.26%	-0.24%
Other operating expenses	-	-	-	-
Net income	-202.93M	-168.78M	-170.22M	-202.60M
Net profit margin	-555.54%	-391.58%	-533.65%	-575.84%
Earnings per share	-	-	-	-
Interest and investment income	1.26M	3.39M	1.61M	939.00K
Interest expense	-	-	-	-
Net interest expenses	1.26M	3.39M	1.61M	939.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-181.20M	-173.67M	-171.53M	-204.17M
Gain or loss from assets sale	-	-	-	-

Finance